News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Mabion S.A. completes marketing authorization application for flagship drug, MabionCD20, to the European Medicines Agency (EMA)
Plexus Ventures would like to share successful news from Mabion S.A. Additional details are provided in Mabion’s press release (Konstantynów Łódzki, 1.06.2018): • Company submitted the marketing authorization application under the centralized authorization procedure...
Plexus Ventures Assists Fujifilm Kyowa Kirin Biologics in Partnering with Mylan of Humira® Biosimilar
Tokyo, Japan – Plexus Ventures is pleased to announce the successful conclusion of an out-licensing project of its client Fujifilm Kyowa Kirin Biologics Co., Ltd. Plexus Ventures provided professional services to Fujifilm Kyowa Kirin Biologics to partner the European...
Events
BIO International Convention - Boston
June 16 – 19, 2025
Click to Schedule a Meeting
CHPI - Frankfurt
October 28 – 30, 2025
Click to Schedule a Meeting
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.